Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Ammonia + lidocaine hydrochloride + povidone-iodine + triamcinolone** is a prescription combination injection kit marketed as **Physician EZ Use Joint Tunnel and Trigger Kit** by **Asclemed USA** for office-based musculoskeletal injections. The clinically important therapeutic component is **triamcinolone acetonide injectable suspension**, a synthetic glucocorticoid corticosteroid that exerts anti-inflammatory and immunosuppressive effects primarily through the **glucocorticoid receptor**. The kit also includes **lidocaine hydrochloride** as a local anesthetic, **povidone-iodine** as an antiseptic preparation component, and **ammonia** as an inhalant component. It is intended for **intramuscular** and **intra-articular** administration and for soft-tissue injection settings such as joint, tunnel, and trigger-point procedures. Publicly available labeling indicates the product has been marketed as an unapproved prescription drug kit and that its labeling has **not been approved by the FDA** as safe and effective.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ammonia + lidocaine hydrochloride + povidone-iodine + triamcinolone.